_version_ 1782245816241487872
author Clarke, AE
Bernatsky, S
Costenbader, KH
Urowitz, MB
Gladman, DD
Fortin, PR
Petri, M
Manzi, S
Isenberg, DA
Rahman, A
Wallace, D
Gordon, C
Peschken, C
Dooley, MA
Ginzler, EM
Aranow, C
Edworthy, SM
Nived, O
Jacobsen, S
Ruiz-Irastorza, G
Yelin, E
Barr, SG
Criswell, L
Sturfelt, G
Dreyer, L
Blanco, I
Gottesman, L
Feldman, CH
Ramsey-Goldman, R
author_facet Clarke, AE
Bernatsky, S
Costenbader, KH
Urowitz, MB
Gladman, DD
Fortin, PR
Petri, M
Manzi, S
Isenberg, DA
Rahman, A
Wallace, D
Gordon, C
Peschken, C
Dooley, MA
Ginzler, EM
Aranow, C
Edworthy, SM
Nived, O
Jacobsen, S
Ruiz-Irastorza, G
Yelin, E
Barr, SG
Criswell, L
Sturfelt, G
Dreyer, L
Blanco, I
Gottesman, L
Feldman, CH
Ramsey-Goldman, R
author_sort Clarke, AE
collection PubMed
description
format Online
Article
Text
id pubmed-3467493
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34674932012-10-12 Lymphoma risk in systemic lupus: effects of treatment versus disease activity Clarke, AE Bernatsky, S Costenbader, KH Urowitz, MB Gladman, DD Fortin, PR Petri, M Manzi, S Isenberg, DA Rahman, A Wallace, D Gordon, C Peschken, C Dooley, MA Ginzler, EM Aranow, C Edworthy, SM Nived, O Jacobsen, S Ruiz-Irastorza, G Yelin, E Barr, SG Criswell, L Sturfelt, G Dreyer, L Blanco, I Gottesman, L Feldman, CH Ramsey-Goldman, R Arthritis Res Ther Meeting Abstract BioMed Central 2012 2012-09-27 /pmc/articles/PMC3467493/ http://dx.doi.org/10.1186/ar3950 Text en Copyright ©2012 Clarke et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Clarke, AE
Bernatsky, S
Costenbader, KH
Urowitz, MB
Gladman, DD
Fortin, PR
Petri, M
Manzi, S
Isenberg, DA
Rahman, A
Wallace, D
Gordon, C
Peschken, C
Dooley, MA
Ginzler, EM
Aranow, C
Edworthy, SM
Nived, O
Jacobsen, S
Ruiz-Irastorza, G
Yelin, E
Barr, SG
Criswell, L
Sturfelt, G
Dreyer, L
Blanco, I
Gottesman, L
Feldman, CH
Ramsey-Goldman, R
Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title_full Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title_fullStr Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title_full_unstemmed Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title_short Lymphoma risk in systemic lupus: effects of treatment versus disease activity
title_sort lymphoma risk in systemic lupus: effects of treatment versus disease activity
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467493/
http://dx.doi.org/10.1186/ar3950
work_keys_str_mv AT clarkeae lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT bernatskys lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT costenbaderkh lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT urowitzmb lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT gladmandd lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT fortinpr lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT petrim lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT manzis lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT isenbergda lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT rahmana lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT wallaced lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT gordonc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT peschkenc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT dooleyma lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT ginzlerem lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT aranowc lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT edworthysm lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT nivedo lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT jacobsens lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT ruizirastorzag lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT yeline lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT barrsg lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT criswelll lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT sturfeltg lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT dreyerl lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT blancoi lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT gottesmanl lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT feldmanch lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity
AT ramseygoldmanr lymphomariskinsystemiclupuseffectsoftreatmentversusdiseaseactivity